Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich OKs $.21 Dividend

NEW YORK (GenomeWeb News) — Sigma-Aldrich’s board yesterday said it will issue an additional share of common stock for each share held as of Dec. 1, 2006.
 
The board also said it has declared a quarterly cash dividend of $.21 per share, which it will pay Dec.15.
 
On Oct. 27 Sigma-Aldrich reported that revenue and profit grew 7 percent in the quarter ended Sept. 30, 2006.
The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.